Metabolic Effects of Eccentric Endurance Training

NCT ID: NCT00722696

Last Updated: 2008-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate metabolic parameters in previously sedentary individuals before and after eccentric endurance training (hiking downwards). Study participants will regularly hike downwards over a difference in altitude of 540 meters during 8 weeks. For the opposite way, a cable car will be used. Metabolic profiles will be obtained at baseline and after the 8 weeks period of eccentric endurance exercise.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolism

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Metabolism Muscles Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

physical training

8 weeks of hiking downwards. For the opposite way, a cable car will be used.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men and women
* age over 18 years

Exclusion Criteria

* previous systematic endurance training (\>3 times per week \>30 min)
* body mass index \> 35 kg/m²
* heavy smoking (\>20 cigarettes per day)
* regular alcohol consumption \>60g per day
* history of cardiovascular disease
* established musculoskeletal disease
* unwillingness to stay in the area for the whole period
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vorarlberg Institute for Vascular Investigation and Treatment

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

VIVIT-Institute

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Heinz Drexel, Prof, MD.

Role: PRINCIPAL_INVESTIGATOR

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT-Institute)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vorarlberg Institute of Vascular Investigation and Treatment

Feldkirch, Vorarlberg, Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Heinz Drexel, Prof, MD

Role: CONTACT

Phone: 004355223032670

Email: [email protected]

Veronika Kiene, PHD

Role: CONTACT

Phone: 004355223032670

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Veronika Kiene, PHD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K01-2008-1

Identifier Type: -

Identifier Source: org_study_id